Yuko Kanbayashi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Peritoneal Dialysis

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Clinical drug investigation

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuko Kanbayashi, Eren Tsuchiya, Tadashi Shimizu, Mayako Uchida
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 32 (1) (2024)
Yuko Kanbayashi, Eren Tsuchiya, Tadashi Shimizu, Mayako Uchida
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2024)
Yuko Kanbayashi, Eren Tsuchiya, Tadashi Shimizu, Mayako Uchida
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 32 (1) (2024)
Yuko Kanbayashi, Sakura Kobayashi, Asuka Kojima, Haruka Wakabayashi, Tadashi Shimizu, Mayako Uchida
Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database. British journal of clinical pharmacology (2024)
Yuko Kanbayashi, Eren Tsuchiya, Tadashi Shimizu, Mayako Uchida
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 32 (1) (2024)
Yuko Kanbayashi, Eren Tsuchiya, Tadashi Shimizu, Mayako Uchida
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 32 (1) (2024)
Yuko Kanbayashi, Tadashi Shimizu, Miku Anzai, Rika Kawai, Mayako Uchida
Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database. Clinical drug investigation (2023)
Yuko Kanbayashi, Tadashi Shimizu, Miku Anzai, Rika Kawai, Mayako Uchida
Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database. Clinical drug investigation 43 (3) (2023)
Yuko Kanbayashi, Tadashi Shimizu, Miku Anzai, Rika Kawai, Mayako Uchida
Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database. Clinical drug investigation 43 (3) (2023)
Yuko Kanbayashi, Mayumi Shimizu, Yuichi Ishizuka, Shohei Sawa, Katsushige Yabe, Mayako Uchida
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis. PloS one 17 (12) (2022)
Yuko Kanbayashi, Mayumi Shimizu, Yuichi Ishizuka, Shohei Sawa, Katsushige Yabe, Mayako Uchida
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis. PloS one 17 (12) (2022)
Yuko Kanbayashi, Mayumi Shimizu, Yuichi Ishizuka, Shohei Sawa, Katsushige Yabe, Mayako Uchida
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis. PloS one 17 (12) (2022)
Yuko Kanbayashi, Yuichi Ishizuka, Mayumi Shimizu, Shohei Sawa, Katsushige Yabe, Mayako Uchida
Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (7) (2022)
Yuko Kanbayashi, Mayumi Shimizu, Yuichi Ishizuka, Shohei Sawa, Katsushige Yabe, Mayako Uchida
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis. PloS one 17 (12) (2022)
Yuko Kanbayashi, Takeshi Ishikawa, Yoshiaki Kuriu, Eigo Otsuji, Koichi Takayama
Predictors for development of oxaliplatin-induced peripheral neuropathy in cancer patients as determined by ordered logistic regression analysis. PloS one 17 (9) (2022)
Yuko Kanbayashi, Mayumi Shimizu, Yuichi Ishizuka, Shohei Sawa, Katsushige Yabe, Mayako Uchida
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis. PloS one 17 (12) (2022)